Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study

NCT02620618 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Behçet's Disease
Uveitis

Interventions

DRUG: Intravitreal Infliximab

Sponsor

Cairo University